文献速递类风湿关节炎

电子患者报告结局测量在炎症性关节炎远程监测中的临床影响:系统综述与Meta分析

The Clinical Impact of Electronic Patient-Reported Outcome Measures in the Remote Monitoring of Inflammatory Arthritis: A Systematic Review and Meta-analysis.
PubMed 文献 · Arthritis Rheumatol · 2023-09-18

该系统综述与Meta分析检索5个数据库,纳入8项研究共4473例患者(7项为类风湿关节炎),评估电子患者报告结局测量(ePROMs)远程监测对疾病活动度、治疗决策和医疗资源利用的影响。与对照相比,ePROM组疾病活动度较低(SMD -0.15;95%CI -0.27至-0.03),缓解/低疾病活动度比例较高(OR 1.65;95%CI 1.02-2.68),但8项研究中5项提供了额外联合干预。远程ePROM组面对面访视需求较少(SMD -0.93;95%CI -2.14-0.28)。

要点

  • ePROM组疾病活动度低于对照组(SMD -0.15;95%CI -0.27至-0.03)。
  • ePROM组缓解/低疾病活动度比例高于对照组(OR 1.65;95%CI 1.02-2.68)。
  • 远程ePROM组面对面访视需求少于对照组(SMD -0.93;95%CI -2.14-0.28)。

核心结论

  • 多数研究存在高偏倚风险且设计异质性显著,但结果提示在炎症性关节炎患者中使用ePROM监测具有优势,有可能减少医疗资源利用而不对疾病结局产生不利影响。

研究设计与样本

  • 检索MEDLINE、Embase、PubMed、Cochrane Library和Web of Science五个数据库,纳入随机对照试验和非随机对照临床试验,对每个结局进行Meta分析和森林图分析。
  • 共纳入8项研究,合计4473例患者,其中7项研究评估类风湿关节炎患者。
  • 使用Risk of Bias-2工具和非随机干预研究偏倚风险评估工具进行偏倚风险评估。

主要发现

  • 与对照相比,ePROM组疾病活动度较低(SMD -0.15;95%CI -0.27至-0.03)。
  • 与对照相比,ePROM组缓解/低疾病活动度比例较高(OR 1.65;95%CI 1.02-2.68)。
  • 8项研究中有5项提供了额外联合干预(如疾病教育)。
  • 远程ePROM组面对面访视需求少于对照组(SMD -0.93;95%CI -2.14-0.28)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 多数研究存在高偏倚风险。
  • 研究设计存在显著异质性。
  • 8项研究中有5项提供了额外联合干预(如疾病教育)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The inflammatory arthritides (IAs) make up a significant proportion of conditions followed up in rheumatology clinics. These patients require regular monitoring, but this is increasingly difficult with rising patient numbers and demand on clinics. Our objective is to evaluate the clinical impact of electronic patient-reported outcome measures (ePROMs) as a digital remote-monitoring intervention on disease activity, treatment decisions, and health care resource use in patients with IA. METHODS: Five databases (MEDLINE, Embase, PubMed, Cochrane Library, and Web of Science) were searched, with randomized controlled trials and (nonrandomized) controlled clinical trials included, and meta-analysis and forest plots conducted for each outcome. Risk of bias was assessed using the Risk of Bias-2 tool and Risk of Bias in Nonrandomized Studies of Interventions. RESULTS: Eight studies were included with a total of 4,473 patients, with seven studies assessing patients with rheumatoid arthritis. Compared with control, the disease activity in the ePROM group was lower (standardized mean difference [SMD] -0.15; 95% confidence interval [CI] -0.27 to -0.03) and rates of remission/low disease activity were higher (odds ratio1.65; 95% CI 1.02-2.68), but five of eight studies provided additional combined interventions (e.g., disease education). Fewer face to face visits were needed in the remote ePROM group (SMD -0.93; 95% CI -2.14-0.28). CONCLUSION: Most studies were at high risk of bias with significant heterogeneity in design, but our results suggest there is an advantage in using ePROM monitoring in patients with IAs, with the potential for reduction in health care resource use without detrimental impact in disease outcomes.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Arumalla N, Chan CKD, Gibson M, et al. The Clinical Impact of Electronic Patient-Reported Outcome Measures in the Remote Monitoring of Inflammatory Arthritis: A Systematic Review and Meta-analysis. Arthritis Rheumatol. 2023. PMID: 37204273. doi:10.1002/art.42559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。